Morgan Stanley’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
|
|||||
2022
Q3 | $3K | Sell |
|
|||||
2022
Q2 | $4K | Sell |
|
|||||
2022
Q1 | $8K | Sell |
|
|||||
2021
Q4 | $32K | Buy |
|
|||||
2021
Q3 | $49K | Sell |
|
|||||
2021
Q2 | $80K | Buy |
|
|||||
2021
Q1 | $66K | Sell |
|
|||||
2020
Q4 | $181K | Buy |
|
|||||
2020
Q3 | $65K | Buy |
|
|||||
2020
Q2 | $56K | Buy |
|
|||||
2020
Q1 | $17K | Sell |
|
|||||
2019
Q4 | $311K | Buy |
|
|||||
2019
Q3 | $40K | Buy |
|
|||||
2019
Q2 | $0 | Sell |
|
|||||
2019
Q1 | $14K | Sell |
|
|||||
2018
Q4 | $129K | Buy |
|